Oppenheimer Initiates Ocular Therapeutix With Outperform

By: via Benzinga
Analysts at Oppenheimer initiated coverage on shares of Ocular Therapeutix (NASDAQ: OCUL) with a Outperform rating. The target price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.